[PDF][PDF] Lornoxicam-loaded nanosponges for controlled anti-inflammatory effect: in vitro/in vivo assessment

SM Shawky, MK Khalifa, HA Eassa - Int. J. Appl. Pharm, 2020 - academia.edu
Objective: To design a controlled topical delivery system of lornoxicam (LX) in order to
enhance skin permeation and treatment efficacy. Nanosponges were selected as a novel …

[PDF][PDF] Design and Characterisation of Tenoxicam Loaded Nanosponges

ER Naik, BP Reddy, SV Saibaba - Int J Trend Innov Res (IJTIIR), 2022 - ijtiir.com
Objective: To design a controlled topical delivery system of Tenoxicam (TX) in order to
enhance skin permeation and treatment efficacy. Nanosponges were selected as a novel …

[PDF][PDF] Journal of Population Therapeutics & Clinical Pharmacology

TTK Niazi, SU Shah, I Shaukat, SA Rashid, H Ullah… - researchgate.net
Lornoxicam is a member of oxicam family and nonsteroidal anti-inflammatory drug (NSAID),
possessing short half-life. This study was opted to fabricate, optimize and evaluate …